Latest News
Aug 13, 2018

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the first generic version of the reference listed drug, Eli Lilly and...

Aug 8, 2018

Our manufacturing partner Meridian Medical Technologies, a Pfizer company, continues to experience interruptions in the production of EpiPen® (epinephrine injection, USP) 0.3 mg and EpiPen Jr®...

Aug 8, 2018

Global pharmaceutical company Mylan N.V.'s (NASDAQ: MYL) board of directors today released the following statement: Over the past decade, Mylan's Board of Directors and management team have turned...

Aug 8, 2018

Mylan N.V. (NASDAQ: MYL) today announced its financial results for the quarter and six months ended June 30, 2018. Second Quarter 2018 Financial Highlights Total revenues of $2.81 billion, down 5%...

Jul 31, 2018

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will release its second quarter 2018 financial results, on Wed., Aug. 8, before the open of the U.S. financial...

View More


Search News Releases

Contact Mylan Communications

Global Communications 
724.514.1968
communications@mylan.com

Stay Connected